Results 221 to 230 of about 983,670 (345)

Low implantation depth during TAVR increases the pressure exerted on the atrioventricular conduction system: a biomechanical analysis [PDF]

, 2017
De Beule, Matthieu, de Jaegere, Peter, El Faquir, Nahid, Mortier, Peter, Rocatello, Giorgia, Segers, Patrick   +5 more
core   +3 more sources

Radiation-Induced Valvular Heart Disease: A Narrative Review of Epidemiology, Diagnosis and Management. [PDF]

J Cardiovasc Dev Dis
Varvara AM, Parasca CA, Iliescu VA, Jurcuț RO.   +3 more
europepmc   +1 more source

Secretopathies emerge as a new class of neurocristopathies

Developmental Dynamics, EarlyView.
Abstract Neural crest cells are a transient embryonic population of cells that give rise to a wide range of structures, including craniofacial cartilage and bone, peripheral neurons and glia, as well as components of the cardiac outflow tract, among others.
Amanda Teixeira, Cassandra Millet‐Boureima, Joshua A. Moore, Loydie A. Jerome‐Majewska   +3 more
wiley   +1 more source

The Valvular Heart Disease-specific Age-adjusted Comorbidity Index (VHD-ACI) score in patients with moderate or severe valvular heart disease. [PDF]

J Geriatr Cardiol
Xie MR, Zhang B, Ye YQ, Li Z, Liu QR, Zhao ZY, Lv JX, Feng DJ, Zhao QH, Zhang HT, Duan ZY, Wang BC, Guo S, Zhao YY, Gao RL, Xu HY, Wu YJ.   +16 more
europepmc   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source

2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation. [PDF]

Eur Heart J Suppl
Adamo M, Massussi M, Marsan NA, Borger MA, Praz F, Metra M.   +5 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Gender differences in clinical profiles, management and outcomes of valvular heart disease in China: insights from a nationwide cohort. [PDF]

BMJ Open
Ma H, Lu Q, Li Z, Ye Y, Zhang B, Wang W, Liu Q, Lv J, Zhao Z, Duan Z, Wang B, Yu Z, Guo S, Zhao Y, Gao R, Wu Y, Xu H.   +16 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Coronary Artery Disease in Patients With Valvular Heart Disease. [PDF]

JACC Asia
Fong FK, So KC.
europepmc   +1 more source